Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., consider how laboratory medicine will continue to evolve to meet health care needs beyond the COVID-19 pandemic.
Every week, Mayo Clinic microbiologist Bobbi Pritt, M.D., posts a new Parasite Wonders case. This weeks case features structures seen in a stool specimen, 110 - 140 micrometers in length, by 75 - 90 micrometers in width. What's the identification?
Top highlights include: side effects of the COVID-19 vaccine, tackling the latest pandemic topics, and World Encephalitis Day.
Alice Gallo De Moraes, M.D., discusses why laboratory testing is important within her practice.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the changing face of laboratory medicine in the time of COVID-19.
Jane Hermansen of Mayo Clinic Labs weighs in on a discussion of uses for expanded testing capacity after the pandemic is over.
Every week, Mayo Clinic microbiologist Bobbi Pritt, M.D., posts a new Parasite Wonders case. This weeks case features a Giemsa-stained preparation of vaginal secretions from a woman with dyspareunia, approximately 15-20 micrometers. What's the identification?
A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.
Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when it should be ordered, and how the results can affect patient care.
This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.
PACE / State of CA / State of FL In this month’s “Virtual Lecture” Yasmeen M. Butt, M.D. will describe the pathology of E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI), how to assess biopsies of suspected EVALI cases, and discuss the controversies surrounding an EVALI diagnosis.